Delivery Order SPE2DR25D3012-SPE2DR26F4C5Q
Award Date 12/1/25
Potential Completion Date 12/2/25
Potential Value $4.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Repaglinide 1 mg tablets in a 90-count package at a firm fixed price of $1,189.32. This is a non-set-aside, competitively awarded contract with an ultimate completion date of December 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order as a child contract under its larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,189.32 to AmerisourceBergen Drug Corp for the supply of Repaglinide 1 mg tablets (90-count units) under a firm fixed price contract. The award was made on November 26, 2025, with an ultimate completion date of November 28, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a non-set-aside, competitively awarded procurement with no small...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Repaglinide 1 mg tablets in quantities of 100 units. This competitively awarded, non-set-aside contract carries a ceiling value of $4,911.34 with firm fixed pricing and an ultimate completion date of July 15, 2025. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a $2,702.96 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Repaglinide 1 mg, a diabetes medication, with performance in Conshohocken, Pennsylvania and completion by November 25, 2025. This non-set-aside, competitively awarded contract reflects firm fixed pricing terms typical of the agency's pharmaceutical procurement operations. AmerisourceBergen Drug Corp, headquartered in Pennsylvania, is a major pharmaceutical distributor serving...
- This federal contract award, with ID SPE2DB20D3103|SPE2DB25FN5D9, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,983,951 units of the medication Repaglinide 1 mg Tablet in 100-count packages, with a ceiling value of $3,113.50. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 22, 2025. The contract is not set aside and was awarded on April 21,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $6,798.50, is for the delivery of 4,563,575,086 units of the pharmaceutical product Repaglinide 1 mg Tablet in 100-count packages. The contract is a Firm Fixed Price Delivery Order with a completion date of February 7, 2024. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Repaglinide 1 mg tablets, a medication used to manage diabetes, with a ceiling value of $13,095.99 and a period of performance through May 6, 2024. The contract was awarded as a Firm Fixed Price Delivery Order and was not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
- The Defense Logistics Agency awarded a $194,050 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100-count bottles of 2 mg Repaglinide tablets. The prime contractor will deliver the generic diabetes medication to a facility in Conshohocken, Pennsylvania by August 17, 2023 in support of the Department of Defense pharmacy programs. No subcontractors or set aside designations were identified. The order was placed under an existing DLA pharmaceutical supply vehicle and...
- This federal contract award, identified as SPE2DB24D1034|SPE2DB25FWAQ2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567321287 units of 1 mg Repaglinide tablets, a medication used to treat type 2 diabetes. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,628.82 and a period of performance through February 21, 2025. This award...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,456.78 for 100 tablets of Nateglinide 120 mg, an oral antidiabetic medication, with a completion date of November 12, 2025. This competitively awarded, firm fixed-price contract was issued on November 10, 2025, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. The award includes no set-aside designation, reflecting the contractor's demonstrated capability...